US7417134B2ExpiredUtilityPatentIndex 63
IL-1 receptor based cytokine traps and method of using
Est. expirySep 25, 2018(expired)· nominal 20-yr term from priority
C07H 21/04C07K 16/244A61P 29/00C07K 2317/622C07K 14/7155A61K 38/00C07K 2319/00C07K 2319/30C07K 2317/73C07K 2319/02C07K 2319/32C07K 14/715
63
PatentIndex Score
2
Cited by
22
References
13
Claims
Abstract
The present invention provides a fusion polypeptide capable of binding interleukin-1 (O:-1) to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of using the fusion polypeptide.
Claims
exact text as granted — not AI-modified1. A recombinant nucleic acid molecule encoding a fusion polypeptide which forms a multimer capable of binding interleukin-1 (IL-1) to form a nonfunctional complex, wherein the nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:51.
2. The nucleic acid of claim 1 encoding a fusion polypeptide comprising the amino acid sequence of SEQ ID NO:52.
3. A vector comprising the nucleic acid molecule of claim 1 .
4. A host-vector system for the production of a fusion polypeptide, comprising the vector of claim 3 in a suitable host cell.
5. A method of producing a fusion polypeptide, comprising growing cells of the host-vector system of claim 4 , under conditions permitting production of the fusion polypeptide and recovering the fusion polypeptide so produced.
6. A recombinant nucleic acid molecule encoding a fusion polypeptide which forms a multimer capable of binding interleukin-1 (IL-1) to form a nonfunctional complex, wherein the nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:53.
7. The nucleic acid of claim 6 encoding a fusion polypeptide comprising the amino acid sequence of SEQ ID NO:54.
8. A recombinant nucleic acid molecule encoding a fusion polypeptide which forms a multimer capable of binding interleukin-1 (IL-1) to form a nonfunctional complex, wherein the nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:55.
9. The nucleic acid of claim 8 encoding a fusion polypeptide comprising the amino acid sequence of SEQ ID NO:56.
10. A fusion polypeptide comprising the amino acid sequence of SEQ ID NO:52.
11. A composition comprising a multimer of the fusion polypeptide of claim 10 .
12. The composition of claim 11 wherein the multimer is a dimer.
13. A method of treating arthritis, comprising administering a therapeutically effective amount of the composition of claim 12 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.